The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...
The novel treatment is in development to address critical cardiac patients with a life-threatening condition and represents a significant milestone for the academic medical system's minimally invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback